Variants in genes associated with immune responses, such as TREM2 (triggering receptor expressed on myeloid cells 2) and CD33, have been linked to an increased risk of neurodegenerative diseases like Alzheimer’s disease (AD) and related disorders. The gene discussed is CD33; the disease is Alzheimer disease.